Draft genomes of Shigella strains used by the STOPENTERICS consortium.

Rossi, Omar; Baker, Kate S; Phalipon, Armelle; Weill, François-Xavier; Citiulo, Francesco; Sansonetti, Philippe; Gerke, Christiane; Thomson, Nicholas R

Rossi, Omar; Baker, Kate S; Phalipon, Armelle; Weill, François-Xavier; Citiulo, Francesco; Sansonetti, Philippe; Gerke, Christiane; Thomson, Nicholas R.

Afiliação

Rossi O; Novartis Vaccines Institute for Global Health, s.r.l., a GSK Company, Siena, Italy.
Baker KS; Wellcome Trust Sanger Institute, Hinxton, UK.
Phalipon A; Institut Pasteur, Paris, France.
Weill FX; Institut Pasteur, Paris, France.
Citiulo F; Novartis Vaccines Institute for Global Health, s.r.l., a GSK Company, Siena, Italy.
Sansonetti P; Institut Pasteur, Paris, France.
Gerke C; Novartis Vaccines Institute for Global Health, s.r.l., a GSK Company, Siena, Italy.
Thomson NR; Wellcome Trust Sanger Institute, Hinxton, UK.

Gut Pathog ; 7: 14, 2015.

Article em En | MEDLINE | ID: mdl-26042182

Palavras-chave

Genome; STOPENTERICS; Shigella; Vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Gut Pathog Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália